Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06333171
PHASE2

4-aminopyridine for Skin Wound Healing

Sponsor: John Elfar

View on ClinicalTrials.gov

Summary

Many patients suffer from chronic non-healing wounds as well as acute wounds. There is a need to develop treatments to accelerate and improve healing of chronic and acute wounds. More research is needed to evaluate the role of 4-aminopyridine (4-AP), a promising new agent with an excellent safety profile, on wound healing. The investigational treatment will be used to evaluate the role of (4-AP) on the treatment of wounds to accelerate wound healing in healthy adults. The purpose of this study is to evaluate the role of 4-AP on the treatment of wounds to accelerate healing. The investigational treatment will be used to test the hypothesis that 4-AP can speed wound healing.

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2025-09

Completion Date

2028-03

Last Updated

2025-09-03

Healthy Volunteers

Yes

Interventions

DRUG

4-Aminopyridine

Active study drug

OTHER

Placebo

Placebo comparator

Locations (1)

University of Arizona

Tucson, Arizona, United States